{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/chronic-kidney-disease/background-information/causes/","result":{"pageContext":{"chapter":{"id":"f36e5c98-76d5-563f-b7e3-a8e580d8edda","slug":"causes","fullItemName":"Causes","depth":2,"htmlHeader":"<!-- begin field c7bc96df-f2e1-4cde-b099-ea29df4758df --><h2>What are the causes and risk factors?</h2><!-- end field c7bc96df-f2e1-4cde-b099-ea29df4758df -->","summary":"","htmlStringContent":"<!-- begin item f90ce268-690c-41b3-957c-a24eaaccd5d5 --><!-- begin field b7c8be8b-13e0-437f-b1cf-e56e92547274 --><p><strong>There are multiple possible causes and risk factors for chronic kidney disease (CKD) and its progression, including:</strong></p><ul><li>Conditions associated with intrinsic kidney damage, such as:<ul><li>Hypertension. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hypertension-not-diabetic/\">Hypertension - not diabetic</a> for more information.</li><li>Diabetes mellitus. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a> and <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-2/\">Diabetes - type 2</a> for more information.</li><li>Glomerular disease, such as acute glomerulonephritis (typically if CKD follows a Streptococcal upper respiratory tract infection; may also follow hepatitis B, hepatitis C, or HIV infection). See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/sore-throat-acute/\">Sore throat - acute</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-c/\">Hepatitis C</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a> for more information.</li></ul></li><li>Current or previous history of acute kidney injury (AKI).<ul><li>This may be triggered by severe intercurrent illness or dehydration. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/acute-kidney-injury/\">Acute kidney injury</a> for more information.</li></ul></li><li>Potentially nephrotoxic drugs, such as:<ul><li>Aminoglycosides, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists (AIIRAs), bisphosphonates, calcineurin inhibitors (such as ciclosporin or tacrolimus), diuretics, lithium, mesalazine, and nonsteroidal anti-inflammatory drugs (NSAIDs).</li></ul></li><li>Conditions associated with obstructive uropathy, such as:<ul><li>Structural renal tract disease.</li><li>Bladder voiding problems such as neurogenic bladder, benign prostatic hypertrophy. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/luts-in-men/\">LUTS in men</a> for more information.</li><li>Urinary diversion surgery.</li><li>Recurrent urinary tract calculi. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/renal-or-ureteric-colic-acute/\">Renal or ureteric colic - acute</a> for more information.</li></ul></li><li>Multisystem diseases with potential renal involvement, such as:<ul><li>Systemic lupus erythematosus (SLE) which may cause lupus nephritis.</li><li>Vasculitis.</li><li>Myeloma. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/multiple-myeloma/\">Multiple myeloma</a> for more information.</li></ul></li><li>A family history of CKD stage 5, or hereditary kidney disease such as autosomal dominant polycystic kidney disease, Alport's syndrome (a sex-linked recessive disease which typically causes haematuria), and familial glomerulonephritis.</li><li>Cardiovascular disease.<ul><li>See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/angina/\">Angina</a>, <a class=\"topic-reference external-reference\" href=\"/topics/cvd-risk-assessment-management/\">CVD risk assessment and management</a>, <a class=\"topic-reference external-reference\" href=\"/topics/heart-failure-chronic/\">Heart failure - chronic</a>, <a class=\"topic-reference external-reference\" href=\"/topics/peripheral-arterial-disease/\">Peripheral arterial disease</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/stroke-tia/\">Stroke and TIA</a> for more information.</li></ul></li><li>Obesity with metabolic syndrome.<ul><li>Obesity alone is not a risk factor for CKD.</li><li>See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/obesity/\">Obesity</a> and <a class=\"topic-reference external-reference\" href=\"/topics/non-alcoholic-fatty-liver-disease-nafld/\">Non-alcoholic fatty liver disease (NAFLD)</a> for more information.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">KDIGO, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Chawla, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">NICE, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Vassalotti, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Gaitonde, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Webster, 2017</a>]</p><!-- end field b7c8be8b-13e0-437f-b1cf-e56e92547274 --><!-- end item f90ce268-690c-41b3-957c-a24eaaccd5d5 -->","topic":{"id":"cf2598e6-fd50-5f3b-8ae0-aad8ebd19ed8","topicId":"ae266062-cc1b-44e2-8118-44e1890750e3","topicName":"Chronic kidney disease","slug":"chronic-kidney-disease","lastRevised":"Last revised in May 2020","chapters":[{"id":"5036566c-74da-5f5a-8ad0-52200f66bacc","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"5b4e7fb9-e75e-5183-b93f-5121d902b8aa","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"75479619-9bb3-51b1-8d45-322a0183327c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"85bf4dec-7d92-5c07-9468-68fd460fa54c","slug":"changes","fullItemName":"Changes"},{"id":"e9caee39-e4d7-55ea-bba5-d1bfb037fab3","slug":"update","fullItemName":"Update"}]},{"id":"94be5ea4-6a52-53bd-9cff-cbc58599fb38","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"af9d912d-8cc7-598f-90cf-201a0152486f","slug":"goals","fullItemName":"Goals"},{"id":"e04a2acd-d3aa-5b29-afe8-4ff8a5cf2527","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c36c8ae1-59b3-5370-8b7b-c879c1c25d17","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1bb64e97-bb95-5733-ba72-d5da80477d5b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0cefa383-4a3f-5e37-8c1d-0cc7b2ba971c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c308ef71-7be3-579d-9b92-dd1e9164c74d","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"34f1f543-1b43-52aa-91e6-43d392ace4b2","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"420f2db7-0bb3-5f08-a35d-671ffd9e83db","slug":"definition","fullItemName":"Definition"},{"id":"f36e5c98-76d5-563f-b7e3-a8e580d8edda","slug":"causes","fullItemName":"Causes"},{"id":"16745b88-79f5-5576-a0a4-704c8cb342e4","slug":"prevalence","fullItemName":"Prevalence"},{"id":"82584375-f9fb-5690-9fe3-f2fb2586f2de","slug":"complications","fullItemName":"Complications"},{"id":"6ddacff5-19b6-5342-b340-25aecbf26dbd","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"00dbd4ad-decc-5bde-b4a3-2599d730c702","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"cdd9f22d-7a2f-5fd6-a9e1-199b0c3ffdfa","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"c6b6c8c3-633d-5062-9804-7b6711e7ddcd","slug":"assessment","fullItemName":"Assessment"},{"id":"3878fa85-9973-5158-8407-20d64dbf148d","slug":"initial-investigations","fullItemName":"Initial investigations"}]},{"id":"579baee5-96e6-5639-a5ee-7dc30540dc8f","fullItemName":"Management","slug":"management","subChapters":[{"id":"07ec0bcd-8fb7-5ae7-87fd-2ff471574c5c","slug":"management-of-chronic-kidney-disease","fullItemName":"Scenario: Management of chronic kidney disease"},{"id":"44ceaa7d-a91b-5472-a7ab-e4bc448067ad","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"b0158ce5-7a78-50df-8843-ded7d59d08e3","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a270530d-7db1-5b03-a1d8-8ff38e242ab9","slug":"ace-inhibitors-aiiras","fullItemName":"ACE-inhibitors and AIIRAs"}]},{"id":"50985320-3b22-5997-85d2-680285318de6","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"168ee77d-eb0d-52d8-a32b-4bda877d21f0","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c8ca80a7-ccf2-5a42-9b8e-72783e1f2131","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"fe26a3ba-fa1b-5c97-8a08-e1f7d193447a","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"854a26b2-4877-59ae-863e-99abcbcad667","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"0af4d212-648e-5a4d-ad67-b1874a49688e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f180e32d-a855-558d-b666-d4c6804afe04","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"ba009e6c-4065-55da-b6c5-bd179af81374","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"34f1f543-1b43-52aa-91e6-43d392ace4b2","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}